Efficacy of brexpiprazole on frequently occurring agitation behaviors in patients with dementia due to Alzheimer’s disease: <i>post hoc</i> pooled analysis of two randomized controlled trials
Patients with agitation associated with dementia due to Alzheimer's disease exhibited many different frequently occurring agitation behaviors. Fixed-dose brexpiprazole 2 or 3 mg/day was associated with a numerically greater reduction in the frequency of most of these frequently occurring agitation behaviors versus placebo.
Authors
- Malaak Brubaker
- Sanjeda R Chumki
- Pedro Such (ORCID: https://orcid.org/0000-0003-1905-1142)
- Zhen Zhang (ORCID: https://orcid.org/0000-0002-6512-1458)
- Anton M. Palma (ORCID: https://orcid.org/0000-0003-1009-4701)
- David Wang (ORCID: https://orcid.org/0000-0001-6274-9947)
Institutions
- Lundbeck (Denmark) (DK)
- Otsuka (United States) (US)
- Deerfield (United States) (US)
- Lundbeck (United States) (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1002/alz.092174
- Primary Topic
- Healthcare Decision-Making and Restraints
- Type
- article
- Field-Weighted Citation Impact
- 0.00